Lisanti Capital Growth’s Crinetics Pharmaceuticals CRNX Stock Holding History

Lisanti Capital Growth’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$953K	Buy
2025 Q1	–	Sell
2024 Q4	$4.23M	Sell
2024 Q3	$5.55M	Buy
2024 Q2	$3.73M	Buy
2024 Q1	$3.24M	Sell
2023 Q4	$3.57M	Buy
2023 Q3	$1.49M	Buy